Clinical trials: HiV1- Positive
- Condition HiV1- Positive
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
HIV Infections
A Study to Investigate the Cardiovascular Safety of Apricitabine in Healthy Subjects
The purpose of this study is to confirm that apricitabine does not induce any clinically significant effect upon electrocardiogram (ECG) parameters at doses consistent with the maximum exposure expected to occur in clinical…
- Trial name
- NCT00334659
- Testing
- apricitabine
- Where
- United States
- Volunteers
- 37 people, healthy volunteers welcome
- Sponsor
- Avexa